technology, Patriot Scientific retains rights to make and market array

microprocessor products and technologies under its current IGNITE(TM) and

INFLAME(TM) brands, as well as a range of other products and technologies not

utilizing the patents covered by this new agreement.

``This accord represents an important milestone for our company,`` said Jeff

Wallin, president and CEO of Patriot Scientific. ``This agreement replaces costly

ongoing litigation with a win-win scenario that supports our efforts to license

and protect our company`s intellectual property on a broader scale. The TPL

Group is well-positioned to aggressively license these core technology patents,

freeing Patriot Scientific to focus on our equally innovative IGNITE and INFLAME

array microprocessor core technologies, as well as other innovations currently

in our development pipeline.``

IGNITE and INFLAME are trademarks of Patriot Scientific Corporation

http://www.ptsc.com/news/press_releases/pr20050607.pdf

Be well